High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002

Epidemiology and Infection

Volumn 134, Issue 6, 2006, Pages 1195-1202

  Smith, Ingrid ^a   Caugant, D A ^b,c   Hoiby E A ^b   Wentzel Larsen, T ^d   Halstensen, A ^a,d  

^a UNIVERSITY OF BERGEN   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; FEMALE; GENOTYPE; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MORTALITY; NEISSERIA MENINGITIDIS; NONHUMAN; NORWAY; PHENOTYPE; SEROTYPE; SEROTYPING; STATISTICAL SIGNIFICANCE;

GENOTYPE; HUMANS; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; NORWAY; PHENOTYPE; SEROTYPING;

EID: 33750318766     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806006248     Document Type: Article

References (38)

1. Bovre K, et al. Some agent characteristics and their coexistence related to occurrence and severity of systemic meningococcal disease in Norway, Winter 1981-1982. NIPH Annals 1983; 6: 75-84.
2. Lystad A, Aasen S. The epidemiology of meningococcal disease in Norway 1975-91. NIPH Annals 1991; 14: 57-65; discussion 65-66.
3. Halstensen A, et al. Case fatality of meningococcal disease in western Norway. Scandinavian Journal of Infectious Diseases 1987; 19: 35-42.
4. Smith I. Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985-2002. Epidemiology and Infection (in press).
5. Spanjaard L, et al. Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83. Bulletin of the World Health. Organization 1987; 65: 861-868.
6. Jensen ES, et al. Period prevalence and case-fatality rate associated with distinctive clone complexes of Neisseria meningitidis serogroups B and C. European Journal of Clinical Microbiology and Infectious Diseases 2002; 21: 506-512.
7. Gedde-Dahl TW, et al. An epidemiological, clinical and microbiological follow-up study of incident meningococcal disease cases in Norway, winter 1981-1982. Material and epidemiology in the MenOPP project. NIPH Annals 1983; 6: 155-168.
8. Frasch CE, Zollinger WD, Poolman JT. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Reviews of Infectious Diseases 1985; 7: 504-510.
9. Wedege E, et al. Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. Journal of Medical Microbiology 1990; 31: 195-201.
10. Selander RK, et al. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Applied and Environmental Microbiology 1986; 51: 871-884.
11. Caugant DA, et al. Intercontinental spread of Neisseria meningitidis clones of the ET-5 complex. Antonie van Leeuwenhoek 1987; 53: 389-394.
12. Maiden MC, et al. Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms. Proceedings of the National Academy of Sciences USA 1998; 95: 3140-3145.
13. Aakre RK, et al. Clonal distribution of invasive Neisseria meningitidis isolates from the Norwegian county of Telemark, 1987 to 1995. Journal of Clinical Microbiology 1998; 36: 2623-2628.
14. Iversen BG, Aavitsland P. Meningococcal disease in Norway 1992-1995. Epidemiology and fatality. Scandinavian Journal of Infectious Diseases 1996; 28: 253-259.
15. Connolly M, Noah N. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. European Meningitis Surveillance Group. Epidemiology and Infection 1999; 122: 41-49.
16. Jensen ES, et al. Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: A 20-year population-based historical follow-up study in a Danish county. Journal of Medical Microbiology 2003; 52: 173-179.
17. Caugant DA. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998; 106: 505-525.
18. Ashton FE, et al. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. Journal of Clinical Microbiology 1991; 29: 2489-2493.
19. Jackson LA, et al. Serogroup C meningococcal outbreaks in the United States. An emerging threat. Journal of the American Medical Association 1995; 273: 383-389.
20. Niklasson PM, Lundbergh P, Strandell T. Prognostic factors in meningococcal disease. Scandinavian Journal of Infectious Diseases 1971; 3: 17-25.
21. Berg S, et al. Incidence, serogroups and case-fatality rate of invasive meningococcal infections in a Swedish region 1975-1989. Scandinavian Journal of Infectious Diseases 1992; 24: 333-338.
22. Scholten RJ, et al. Patient and strain characteristics in relation to the outcome of meningococcal disease: A multivariate analysis. Epidemiology and Infection 1994; 112: 115-124.
23. Shigematsu M, et al. National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001. Epidemiology and Infection 2002; 129: 459-470.
24. Cartwright K. Meningococcal carriage and disease. In: Cartwright K, ed. Meningococcal Disease. New York: John Wileys & Sons, 1995, pp. 115-146.
25. Smith I, et al. Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: Effect of vaccination and selective carriage eradication. Epidemiology and Infection 1999; 123: 373-382.
26. Sacchi CT, et al. Ongoing group B Neisseria meningitidis epidemic in Sao Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. Journal of Clinical Microbiology 1992; 30: 1734-1738.
27. Scholten RJ, et al. Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clinical Infectious Diseases 1993; 16: 237-246.
28. Whalen CM, et al. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. Journal of the American Medical Association 1995; 273: 390-394.
29. Caugant DA, et al. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proceedings of the National Academy of Sciences USA 1986; 83: 4927-4931.
30. Maiden MC. Population genetics of a transformable bacterium: The influence of horizontal genetic exchange on the biology of Neisseria meningitidis. FEMS Microbiology Letters 1993; 112: 243-250.
31. Caugant DA, et al. Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986. Journal of Infectious Diseases 1990; 162: 867-874.
32. Wedege E, et al. Emergence of a new virulent clone within the electrophoretic type 5 complex of serogroup B meningococci in Norway. Clinical and Diagnostic Laboratory Immunology 1995; 2: 314-321.
33. Swartley JS, et al. Capsule switching of Neisseria meningitidis. Proceedings of the National Academy of Sciences USA 1997; 94: 271-276.
34. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. Journal of Experimental Medicine 1969; 129: 1327-1348.
35. Bille E, et al. A chromosomally integrated bacteriophage in invasive meningococci. Journal of Experimental Medicine 2005; 201: 1905-1913.
36. Booy R, et al. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Archives of Disease in Childhood 2001; 85: 386-390.
37. Thorburn K, et al. Mortality in severe meningococcal disease. Archives of Disease in Childhood 2001; 85: 382-385.
38. Peltola H. Meningococcal disease: Still with us. Reviews of Infectious Diseases 1983; 5: 71-91.